August 6th 2025, 6:55pm
The U.S. FDA granted accelerated approval to Modeyso for patients with diffuse midline glioma with an H3 K27M mutation with progressive disease.
August 6th 2025, 5:00pm
Following the June 2025 FDA approval of Datroway, Dr. Jacob A. Sands explained the significance of the regulatory approval for patients with lung cancer.
August 6th 2025, 4:00pm
During my breast cancer journey, my sister Kelly’s love and support — especially the day she shaved my head — gave me strength, comfort, and control.
August 6th 2025, 2:55pm
The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma after two prior therapies.
August 6th 2025, 1:00pm
LaShae D. Rolle discusses how maintaining physical activity during active breast cancer treatment may impact a patients mental and emotional well-being.
August 5th 2025, 9:00pm
When my daughter had cancer, my other children carried our family with grace, compassion and strength I didn’t know I’d one day need from them.
August 5th 2025, 8:00pm
Existing autoimmune drugs may prevent or reverse a serious side effect faced by patients with cancer.
August 5th 2025, 7:00pm
TAMs may help predict response to PD-1 inhibitors in metastatic clear cell kidney cancer, Dr. Berkay Simsek reported at the 2025 Kidney Cancer Summit.
August 5th 2025, 5:00pm
After my cancer diagnosis, I planned to go it alone but found unconditional acceptance from the cancer community once I took the first step.
August 5th 2025, 4:00pm
An expert helps patients with metastatic breast cancer understand treatment sequencing, biomarker testing and emerging options to support decision-making.
Challenging Assumptions About Cancer and Its Treatments
Sharing Stories of Survivorship
Perioperative Therapy in Resectable NSCLC: The Drive for a Cure
How My Daughter Stood Up to Breast Cancer